Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov-Dec;32(6):949-959.
doi: 10.1111/wrr.13224. Epub 2024 Sep 26.

Digital ulcers associated with scleroderma: A major unmet medical need

Affiliations
Review

Digital ulcers associated with scleroderma: A major unmet medical need

Angha Naik et al. Wound Repair Regen. 2024 Nov-Dec.

Abstract

Scleroderma or systemic sclerosis (SSc)-associated digital ischaemic complications, such as digital ulcers (SSc-DUs), appear relatively early during the disease course and are a major burden with substantial deterioration of quality of life. Expert rheumatologist and wound specialists have defined a DU; however, international application of the definition is still disorganised. Appearance of SSc-DUs is secondary to the onset of Raynaud's phenomenon and as a consequence, recommended first-line of treatment mainly includes vasodilators; however, many DUs are refractory to this treatment. Despite important practical issues, such as a lack of well-characterised SSc-wound healing animal model, significant efforts are needed to mechanistically understand the pathogenesis of SSc-DUs for developing clinically targetable disease modifying therapies.

Keywords: chronic wound; connective tissue; rheumatology; scleroderma.

PubMed Disclaimer

References

REFERENCES

    1. Li JX. Secular trends in systemic sclerosis mortality in the United States from 1981 to 2020. Int J Environ Res Public Health. 2022;19:15088.
    1. Bukiri H, Volkmann ER. Current advances in the treatment of systemic sclerosis. Curr Opin Pharmacol. 2022;64:102211.
    1. Leask A, Naik A, Stratton RJ. Back to the future: targeting the extracellular matrix to treat systemic sclerosis. Nat Rev Rheumatol. 2023;19:713‐723.
    1. Boin F, Hummers LK. Scleroderma‐like fibrosing disorders. Rheum Dis Clin North Am. 2008;34:199‐220.
    1. Showalter K, Gordon JK. Skin histology in systemic sclerosis: a relevant clinical biomarker. Curr Rheumatol Rep. 2021;23:3.

Publication types

LinkOut - more resources